- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: carfilzomib, lenalidomide plus dexamethasone
Total 540 results
-
Cancer Trials IrelandCompleted
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Xijing HospitalRecruitingNewly-diagnosed Ph+ Acute Lymphoblastic LeukemiaChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsActive, not recruitingMultiple MyelomaUnited States
-
Fundación Pública Andaluza para la gestión de la...RecruitingPrimary Immune ThrombocytopeniaSpain
-
University Health Network, TorontoBayerActive, not recruitingMetastatic Prostate CancerCanada
-
SanofiCompleted
-
Sun Pharmaceutical Industries LimitedWithdrawn
-
Sun Yat-sen UniversityRecruitingMyeloma | Newly Diagnosed | High RiskChina
-
Sun Pharmaceutical Industries LimitedCompleted
-
Hackensack Meridian HealthMerck Sharp & Dohme LLCCompletedMultiple MyelomaUnited States
-
University of ChicagoNational Cancer Institute (NCI)RecruitingRefractory Multiple MyelomaUnited States
-
Sheikh Zayed Medical CollegeRecruitingPost Operative PainPakistan
-
Intergroupe Francophone du MyelomeCompleted
-
The First Hospital of Jilin UniversityUnknownMultiple Myeloma in RelapseChina
-
Tel-Aviv Sourasky Medical CenterWeizmann Institute of ScienceRecruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryIsrael
-
SunovionCompletedPerennial Allergic RhinitisUnited States
-
US Oncology ResearchKaryopharm Therapeutics IncRecruitingMultiple Myeloma | Plasma Cell Myeloma | Myeloma-Multiple | Myeloma Multiple | Kahler Disease | Myeloma, Plasma Cell | MyelomatosisUnited States
-
National Cancer Institute (NCI)CompletedStage II Multiple Myeloma | Stage III Multiple Myeloma | Multiple Myeloma in RelapseUnited States
-
National Cancer Institute (NCI)Active, not recruitingRefractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
The First Affiliated Hospital of Soochow UniversityThe First Affiliated Hospital with Nanjing Medical University; Jiangsu Province... and other collaboratorsRecruiting
-
Weill Medical College of Cornell UniversityCelgeneCompletedMultiple MyelomaUnited States
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, South Africa
-
Arbeitsgemeinschaft medikamentoese TumortherapieMedical University of Vienna; Sanofi; Assign Data Management and Biostatistics... and other collaboratorsRecruitingNewly Diagnosed Multiple MyelomaAustria, Greece, Serbia
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Australia, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Spain, United Kingdom
-
Hackensack Meridian HealthOnyx Therapeutics, Inc.CompletedWaldenstrom MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstituteAmgenCompletedWaldenstrom's MacroglobulinemiaUnited States
-
Mayo ClinicCompletedRefractory Multiple MyelomaUnited States
-
Tianjin University of Traditional Chinese MedicineNational Basic Research Program, ChinaUnknownChemotherapy-induced Nausea and VomitingChina
-
Xia ZhongjunAntengene CorporationRecruiting
-
University of ChicagoNational Cancer Institute (NCI); Multiple Myeloma Research FoundationRecruitingMultiple MyelomaUnited States, Canada
-
Johns Hopkins UniversityTerminated
-
Peking UniversityUnknownChemotherapy Effect | Esophageal Cancer, Squamous Cell | Cetuximab EffectChina
-
NYU Langone HealthCelgeneTerminatedMultiple MyelomaUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
LEO PharmaCompleted
-
Poitiers University HospitalSanofi; Celgene; Amgen; Intergroupe Francophone du MyelomeActive, not recruitingMultiple Myeloma in Relapse | Multiple Myeloma, RefractoryFrance
-
Tragara Pharmaceuticals, Inc.CompletedMultiple Myeloma | AML | Blast Crisis | MDS | ALLUnited States
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Italy, Czechia, Denmark, France, Germany, Greece, Spain
-
Emory UniversityNovartis; University of Chicago; University of California, San Francisco; Amgen; Onyx... and other collaboratorsCompletedMultiple MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Jordan University of Science and TechnologyActive, not recruiting
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
European Myeloma NetworkUniversity of Turin, ItalyCompleted
-
National Cancer Institute (NCI)CompletedAnemia | Refractory Multiple Myeloma | Recurrent Multiple MyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationTerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Samsung Medical CenterRecruiting
-
AbbVieTerminatedMultiple MyelomaUnited States, Australia, France, Germany, Israel, Japan, Spain